Peterson Financial Group, Inc. Eli Lilly & CO Transaction History

Peterson Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $9,475 - $12,676	-16 Reduced 0.43%	3,743 $2.91 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $749,971 - $884,117	1,428 Added 61.26%	3,759 $2.19 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $38,253 - $52,738	88 Added 3.92%	2,331 $1.25 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $208,690 - $279,043	595 Added 36.1%	2,243 $1.05 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $325,540 - $382,331	1,048 Added 174.67%	1,648 $565,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $192,930 - $224,802	600 New	600 $219,000

3,865

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Peterson Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Peterson Financial Group, Inc. with notifications on news.